临时机械循环支持桥接心脏移植的移植后结局
基于国际心肺移植学会胸科移植登记库2005-2016年数据,纳入6,528例机械循环支持桥接移植患者,比较临时机械循环支持与持久连续流左心室辅助装置(CF-LVAD)桥接者的移植后生存。ECMO桥接(HR 3.79,95%CI 2.69-5.34,p<0.001)和经皮临时CF-LVAD桥接(HR 1.83,95%CI 1.09-3.08,p=0.02)与死亡风险升高独立相关。供者年龄较大、供受体性别匹配、受者年龄较大、受者体重指数较高、受者肌酐较高及缺血时间延长也是危险因素。
要点
- ECMO桥接移植与死亡风险升高独立相关(HR 3.79)。
- 经皮临时CF-LVAD桥接亦与死亡风险升高相关(HR 1.83)。
- 供受体年龄、BMI、肌酐及缺血时间影响移植后生存。
核心结论
- ECMO和经皮临时CF-LVAD桥接移植是移植后死亡的预测因素。
- 供者和受者临床特征亦与移植后结局相关。
研究设计与样本
- 回顾性队列研究,利用国际心肺移植学会胸科移植登记库2005-2016年数据。
- 纳入6,528例已知使用机械循环支持的心脏移植受者。
主要发现
- 持久CF-LVAD桥接6,206例,ECMO 134例,经皮临时CF-LVAD 75例,手术植入临时CF-LVAD 38例,手术植入临时BiVAD 75例。
- ECMO桥接与死亡风险升高独立相关(HR 3.79,95%CI 2.69-5.34,p<0.001)。
- 经皮临时CF-LVAD桥接与死亡风险升高独立相关(HR 1.83,95%CI 1.09-3.08,p=0.02)。
- 其他危险因素包括供者年龄较大、供受体性别匹配、受者年龄较大、受者BMI较高、受者肌酐较高及缺血时间延长。
临床怎么用
- 选择机械循环支持装置时需考虑ECMO和经皮临时CF-LVAD桥接的较高死亡风险。
- 评估移植候选资格和时机时应综合供受体临床特征。
局限性
- 回顾性登记研究,可能存在未测量混杂因素。
- 临时机械循环支持亚组样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The new heart allocation system in the United States prioritizes patients supported by temporary mechanical circulatory support (TMCS) devices over those with uncomplicated durable continuous-flow left ventricular assist devices (CF-LVADs), which may increase the number of patients bridged to transplant with TMCS. Limited data are available in guiding post-transplant outcomes with various TMCS devices. We sought to describe post-transplant outcome and identify clinical variables associated with post-transplant outcome in patients bridged to transplant with TMCS. METHODS: Using data from the International Society for Heart and Lung Transplantation Thoracic Transplant Registry, we included subjects who underwent transplantation between 2005 and 2016 with known use of mechanical circulatory support. Pre-transplant recipient, donor, and transplant-specific variables were abstracted. The primary outcome was patient survival at 1-year post-transplant. Outcomes of patients bridged to transplant with TMCS were compared with those of patients bridged with CF-LVADs. Cox regression analyses were performed to identify clinical variables associated with the outcomes. RESULTS: There were 6,528 patients bridged to transplant with the following types of mechanical circulatory support: durable CF-LVADs (n = 6,206), extracorporeal membrane oxygenation (ECMO, n = 134), percutaneous temporary CF-LVADs (n = 75), surgically implanted temporary CF-LVADs (n = 38) or surgically implanted temporary BiVAD (n = 75). Bridging with ECMO (hazard ratio 3.79, 95% confidence interval [CI] 2.69-5.34, p < 0.001) or percutaneous temporary CF-LVADs (hazard ratio 1.83, 95% CI 1.09-3.08, p = 0.02) was independently associated with higher risk of mortality. Additional risk factors included older donor age, female/male donor-recipient match, older recipient age, higher recipient body mass index, higher recipient creatinine, and prolonged ischemic time. CONCLUSIONS: This analysis of a large international cohort of patients bridged to transplant with mechanical circulatory support identified ECMO and percutaneous temporary CF-LVADs as predictors of mortality after transplant, along with additional donor and recipient clinical characteristics. These findings may provide guidance to clinicians in decisions on mechanical circulatory support device selection, transplant eligibility, and timing of transplant.
引用
- Yin MY, Wever-Pinzon O, Mehra MR, et al. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019. PMID: 31072751. doi:10.1016/j.healun.2019.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。